NCT06210230View on ClinicalTrials.gov

Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms

NACompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

November 22, 2023

Study Completion Date

December 10, 2023

Conditions

Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

MLCT supplementation

MLCT 25g/d for 6 months

DIETARY_SUPPLEMENT

Olive oil

Matching placebo (olive oil) 25g/d for 6 months

Trial Locations (1)

321102

Lanxi Traditional Chinese Medicine Hospital, Jinhua

All Listed Sponsors

lead

Zhejiang University

OTHER

NCT06210230 - Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms | Biotech Hunter | Biotech Hunter